Correction: MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation (Journal of Nanoscience and Nanotechnology (2017) 292 (16420-16439) DOI: 10.1074/jbc.M117.805747);MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation

Journal of Biological Chemistry

Volumn 292, Issue 40, 2017, Pages 16420-16439

  Huang, Chaoqun ^a   Xiao, Xiao ^a   Yang, Ye ^a   Mishra, Amorite ^a   Liang, Yurong ^a   Zeng, Xiangming ^a   Yang, Xiaoyun ^a   Xu, Dao ^a   Blackburn, Michael R ^b   Henke, Craig A ^c   Liu, Lin ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHEMICAL ACTIVATION; FIBROBLASTS; GENE TRANSFER; MAMMALS; PATIENT TREATMENT; PEPTIDES; RNA; TRANSCRIPTION;

DOWN-REGULATION; FIBROBLAST PROLIFERATION; IDIOPATHIC PULMONARY FIBROSIS; LUNG FIBROBLASTS; LUNG FIBROSIS; LUNG FUNCTION; PULMONARY FIBROSIS; THERAPEUTIC TARGETS;

BIOLOGICAL ORGANS;

ADENOVIRUS VECTOR; FRIZZLED PROTEIN; FRIZZLED RECEPTOR 4; FRIZZLED RECEPTOR 6; MICRORNA 101; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; WNT5A PROTEIN; BLEOMYCIN; FZD4 PROTEIN, HUMAN; FZD4 PROTEIN, MOUSE; FZD6 PROTEIN, HUMAN; FZD6 PROTEIN, MOUSE; MICRORNA; MIRN101 MICRORNA, HUMAN; MIRN101 MICRORNA, MOUSE; NFATC2 PROTEIN, HUMAN; NFATC2 PROTEIN, MOUSE; SMAD2 PROTEIN, HUMAN; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN, HUMAN; SMAD3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG FUNCTION; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION;

ANIMALS; BLEOMYCIN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FIBROBLASTS; FRIZZLED RECEPTORS; HUMANS; MALE; MICE; MICRORNAS; NFATC TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-ETS; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN;

EID: 85030761497     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC119.008714     Document Type: Erratum

References (42)

1. Ramos, C., Montano, M., García-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., and Pardo, A. (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell Mol. Biol. 24, 591–598
2. Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., and Thannickal, V. J. (2009) NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15, 1077–1081
3. Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., and Borok, Z. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166, 1321–1332
4. Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., and Chapman, H. A. (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 103, 13180 –13185
5. Tanjore, H., Xu, X. C., Polosukhin, V. V., Degryse, A. L., Li, B., Han, W., Sherrill, T. P., Plieth, D., Neilson, E. G., Blackwell, T. S., and Lawson, W. E. (2009) Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 180, 657– 665
6. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., and Strieter, R. M. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438 – 446
7. Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., and Toews, G. B. (2006) The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35, 175–181
8. Xia, H., Bodempudi, V., Benyumov, A., Hergert, P., Tank, D., Herrera, J., Braziunas, J., Larsson, O., Parker, M., Rossi, D., Smith, K., Peterson, M., Limper, A., Jessurun, J., Connett, J., Ingbar, D., Phan, S., Bitterman, P. B., and Henke, C. A. (2014) Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. Am. J. Pathol. 184, 1369 –1383
9. Steele, M. P., and Schwartz, D. A. (2013) Molecular mechanisms in progressive idiopathic pulmonary fibrosis. Annu. Rev. Med. 64, 265–276
10. Wolters, P. J., Collard, H. R., and Jones, K. D. (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu. Rev. Pathol. 9, 157–179
11. Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M., Handley, D., Richards, T., Selman, M., Watkins, S. C., Pardo, A., Ben-Yehudah, A., et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182, 220 –229
12. Cushing, L., Kuang, P. P., Qian, J., Shao, F., Wu, J., Little, F., Thannickal, V. J., Cardoso, W. V., and Lü, J. (2011) MIR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 287–294
13. Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., and Bitterman, P. B. (2014) Fi-brotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124, 1622–1635
14. Montgomery, R. L., Yu, G., Latimer, P. A., Stack, C., Robinson, K., Dalby, C. M., Kaminski, N., and van Rooij, E. (2014) MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol. Med. 6, 1347–1356
15. Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., and Abraham, E. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207, 1589 –1597
16. Bodempudi, V., Hergert, P., Smith, K., Xia, H., Herrera, J., Peterson, M., Khalil, W., Kahm, J., Bitterman, P. B., and Henke, C. A. (2014) miR-210 promotes IPF fibroblast proliferation in response to hypoxia. Am. J. Physiol. Lung Cell Mol. Physiol 307, L283–L294
17. Das, S., Kumar, M., Negi, V., Pattnaik, B., Prakash, Y. S., Agrawal, A., and Ghosh, B. (2014) MicroRNA-326 regulates profibrotic functions of transforming growth factor- in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 50, 882– 892
18. Xiao, X., Huang, C., Zhao, C., Gou, X., Senavirathna, L. K., Hinsdale, M., Lloyd, P., and Liu, L. (2015) Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. Arch. Biochem. Biophys. 566, 49 –57
19. Oak, S. R., Murray, L., Herath, A., Sleeman, M., Anderson, I., Joshi, A. D., Coelho, A. L., Flaherty, K. R., Toews, G. B., Knight, D., Martinez, F. J., and Hogaboam, C. M. (2011) A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE 6, e21253
20. Vuga, L. J., Ben-Yehudah, A., Kovkarova-Naumovski, E., Oriss, T., Gibson, K. F., Feghali-Bostwick, C., and Kaminski, N. (2009) WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am. J. Respir. Cell Mol. Biol. 41, 583–589
21. Sato, A., Yamamoto, H., Sakane, H., Koyama, H., and Kikuchi, A. (2010) Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J. 29, 41–54
22. Dejmek, J., Safholm, A., Kamp Nielsen, C., Andersson, T., and Leander-sson, K. (2006) Wnt-5a/Ca2-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1 signaling in human mammary epithelial cells. Mol. Cell Biol. 26, 6024 – 6036
23. Thannickal, V. J., Lee, D. Y., White, E. S., Cui, Z., Larios, J. M., Chacon, R., Horowitz, J. C., Day, R. M., and Thomas, P. E. (2003) Myofibroblast differentiation by transforming growth factor-1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278, 12384 –12389
24. Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., and Gauldie, J. (1997) Adenovector-mediated gene transfer of active transforming growth factor-1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100, 768–776
25. Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., Brenner, J. C., Yu, J., Kim, J. H., Han, B., Tan, P., et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322, 1695–1699
26. Frankel, L. B., Wen, J., Lees, M., Høyer-Hansen, M., Farkas, T., Krogh, A., Jäättelä, M., and Lund, A. H. (2011) microRNA-101 is a potent inhibitor of autophagy. EMBO J. 30, 4628 – 4641
27. Xu, Y., An, Y., Wang, Y., Zhang, C., Zhang, H., Huang, C., Jiang, H., Wang, X., and Li, X. (2013) miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol. Rep. 29, 2019 –2024
28. Smits, M., Mir, S. E., Nilsson, R. J., van der Stoop, P. M., Niers, J. M., Marquez, V. E., Cloos, J., Breakefield, X. O., Krichevsky, A. M., Noske, D. P., Tannous, B. A., and Würdinger, T. (2011) Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS ONE 6, e16282
29. Kim, J. H., Lee, K. S., Lee, D. K., Kim, J., Kwak, S. N., Ha, K. S., Choe, J., Won, M. H., Cho, B. R., Jeoung, D., Lee, H., Kwon, Y. G., and Kim, Y. M. (2014) Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3. Antioxid. Redox. Signal. 21, 2469 –2482
30. Zhu, Q. Y., Liu, Q., Chen, J. X., Lan, K., and Ge, B. X. (2010) MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J. Im-munol. 185, 7435–7442
31. Tu, X., Zhang, H., Zhang, J., Zhao, S., Zheng, X., Zhang, Z., Zhu, J., Chen, J., Dong, L., Zang, Y., and Zhang, J. (2014) MicroRNA-101 suppresses liver fibrosis by targeting the TGF signalling pathway. J. Pathol. 234, 46–59
32. Pan, Z., Sun, X., Shan, H., Wang, N., Wang, J., Ren, J., Feng, S., Xie, L., Lu, C., Yuan, Y., Zhang, Y., Wang, Y., Lu, Y., and Yang, B. (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-1 pathway. Circulation 126, 840 – 850
33. Wang, L., Zhang, X., Jia, L. T., Hu, S. J., Zhao, J., Yang, J. D., Wen, W. H., Wang, Z., Wang, T., Zhao, J., Wang, R. A., Meng, Y. L., Nie, Y. Z., Dou, K. F., Chen, S. Y., Yao, L. B., Fan, D. M., Zhang, R., and Yang, A. G. (2014) c-Myc-mediated epigenetic silencing of microRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatol-ogy 59, 1850 –1863
34. Baran, C. P., Fischer, S. N., Nuovo, G. J., Kabbout, M. N., Hitchcock, C. L., Bringardner, B. D., McMaken, S., Newland, C. A., Cantemir-Stone, C. Z., Phillips, G. S., Ostrowski, M. C., and Marsh, C. B. (2011) Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 999 –1006
35. Kasinski, A. L., and Slack, F. J. (2010) Potential microRNA therapies targeting Ras, NFB and p53 signaling. Curr. Opin. Mol. Ther. 12, 147–157
36. Chen, Z., Chintagari, N. R., Guo, Y., Bhaskaran, M., Chen, J., Gao, L., Jin, N., Weng, T., and Liu, L. (2007) Gene expression of rat alveolar type II cells during hyperoxia exposure and early recovery. Free Radic. Biol. Med. 43, 628 – 642
37. Chen, Z., and Liu, L. (2005) RealSpot: software validating results from DNA microarray data analysis with spot images. Physiol. Genomics. 21, 284–291
38. Huang, C., Xiao, X., Chintagari, N. R., Breshears, M., Wang, Y., and Liu, L. (2014) MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome. BMC. Med. Genomics 7, 46
39. Bhaskaran, M., Wang, Y., Zhang, H., Weng, T., Baviskar, P., Guo, Y., Gou, D., and Liu, L. (2009) MicroRNA-127 modulates fetal lung development. Physiol. Genomics 37, 268 –278
40. Zhao, C., Huang, C., Weng, T., Xiao, X., Ma, H., and Liu, L. (2012) Computational prediction of microRNAs targeting GABA receptors and experimental verification of miR-181, miR-216 and miR-203 targets in GABA-A receptor. BMC. Res. Notes 5, 91
41. Bruce, M. C., Honaker, C. E., and Cross, R. J. (1999) Lung fibroblasts undergo apoptosis following alveolarization. Am. J. Respir. Cell Mol. Biol. 20, 228 –236
42. Ashcroft, T., Simpson, J. M., and Timbrell, V. (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467– 470